BioAge Labs (BIOA) Faces Securities Class Action On Behalf Of IPO Investors After Discontinuing Weight-Loss Drug Trial– Hagens Berman
10. Januar 2025 08:40 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is facing a class-action lawsuit from shareholders who allege...
Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report– Hagens Berman
10. Januar 2025 08:38 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) faces a securities fraud class action after shares of the company plunged $84.59 on Oct. 31, 2024,...
Celsius Holdings (CELH) Hit with Investor Class Action Amid Accusations of Oversold Inventory to Pepsi– Hagens Berman
09. Januar 2025 14:39 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Shares of Celsius Holdings (NASDAQ: CELH), the energy drink maker already reeling from a 58 percent year-to-date decline, faced renewed pressure this...
Symbotic (SYM) Restates Financial Results Amid Securities Class Action Over Improper Accounting – Hagens Berman
09. Januar 2025 14:34 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (NASDAQ: SYM), a Wilmington, Mass.-based automation technology company, has filed restated financial statements for three fiscal 2024...
PACS Group (PACS) Investors with Losses Encouraged to Contact Hagens Berman Before Jan. 13, 2025 Deadline in Securities Class Action
09. Januar 2025 11:46 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 09, 2025 (GLOBE NEWSWIRE) -- PACS Group (NYSE: PACS), a nursing home operator that saw its stock soar after its initial public offering in April, has experienced a precipitous...
Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report– Hagens Berman
08. Januar 2025 21:29 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) faces a securities fraud class action after shares of the company plunged $84.59 on Oct. 31, 2024,...
Carvana (CVNA) Shares Tumble as Forensic Research Firm Hindenburg Takes Aim, Concludes Company’s Turnaround is a “Mirage” – Hagens Berman
08. Januar 2025 09:27 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Carvana Co. (NYSE: CVNA) shares tumbled nearly 13% during the two days ended Jan. 3, 2025 as the market digested a scathing report published by...
Symbotic (SYM) Restates Financials, Faces Scrutiny Amid Accounting Concerns – Hagens Berman
07. Januar 2025 20:39 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (NASDAQ: SYM), a Wilmington, Mass.-based automation technology company, has filed restated financial statements for three fiscal 2024...
BioAge Labs (BIOA) Faces Securities Class Action On Behalf Of IPO Investors After Discontinuing Weight-Loss Drug Trial– Hagens Berman
07. Januar 2025 20:36 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is facing a class-action lawsuit from shareholders who allege...
Analyst Downgrade Fuels Further Decline for Celsius (CELH) Shares Amid Sales Concerns and Investor Lawsuit– Hagens Berman
07. Januar 2025 19:44 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Shares of Celsius Holdings (NASDAQ: CELH), the energy drink maker already reeling from a 58 percent year-to-date decline, faced renewed pressure this...